Rockwell Medical: Triple-Digit Upside Potential On Triferic Approval
- Rockwell Medical stands to benefit from Calcitriol, which was approved this year and the company is ready to launch in late 2014.
- Triferic's approval in January 2015 would lead to significant upside.
- Reward/risk ratio is highly skewed to the long side.
- Additional downside should be limited even if Triferic does not get approved.